Corrigendum to 'Direct 3D bioprinting of perfusable vascular constructs using a blend bioink' [Biomaterials Volume 106, (2016) Pages 58-68].

Biomaterials

Biomaterials Innovation Research Center, Division of Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, 02139, USA; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, 02139, U

Published: November 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2025.123364DOI Listing

Publication Analysis

Top Keywords

corrigendum 'direct
4
'direct bioprinting
4
bioprinting perfusable
4
perfusable vascular
4
vascular constructs
4
constructs blend
4
blend bioink'
4
bioink' [biomaterials
4
[biomaterials volume
4
volume 106
4

Similar Publications

Corrigendum to "Current status and future direction of mechanotransduction mechanisms: Perspectives from cell membrane to nucleus" [Biochem. Biophys. Res. Commun. 781 (2025) 152524].

Biochem Biophys Res Commun

September 2025

State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School and Hospital of Stomatology, Wuhan University, Wuhan, 430079, People's Republic of China. Electronic address: guoliang@w

View Article and Find Full Text PDF

Corrigendum to "Spatial variability and directional shifts in postural control in Parkinson's disease" [Clin. Parkinsonism Relat. Disord. (2024) 10, 100249].

Clin Park Relat Disord

February 2025

Division of Biomechanics and Research Development, Department of Biomechanics, Center for Research in Human Movement Variability, University of Nebraska at Omaha, Omaha, NE 68182, USA.

[This corrects the article DOI: 10.1016/j.prdoa.

View Article and Find Full Text PDF

Corrigendum to "Sonorheometry parameters during dabigatran reversal with idarucizumab for major bleeding" [The Journal of Pharmacology and Experimental Therapeutics 392 (2025) 103605].

J Pharmacol Exp Ther

July 2025

Emergency Department, Centre hospitalier universitaire Clermont-Ferrand, Clermont-Ferrand, France; Université Clermont Auvergne, Institut national de recherche pour l'agriculture, l'alimentation et l'environnement, Unité de Nutrition humaine, Unité de Nutrition Humaine, Centre de recherche en Nut

View Article and Find Full Text PDF